A Phase 1 Randomised, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INI-822 in Healthy Volunteers and Participants with Non-Alcoholic Steatohepatitis (NASH) Or Presumed NASH

  • Roberts, Stuart (Primary Chief Investigator (PCI))
  • Mitchell, Jo (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date27/08/24 → 26/08/26

Keywords

  • Clinical Trials
  • INI-822-001